On 29 October, German-based company EW Nutrition will officially open its new 
production plant in China. The new plant is the next step in the successful 
development of EWN Biotechnology Shanghai.

By offering holistic, science-backed solutions, EW Nutrition supports the 
Chinese industry in its effort to reduce antibiotic use. "With this latest 
investment," says Craige Allen, General Manager, EWN Biotechnology Shanghai, 
"We are offering a twofold benefit to our Chinese customers: bringing our 
high-value products closer to the end user, while implementing our policy of 
supporting antibiotic-free production in China."

The new facility in Haimen will produce the three leading product lines in the 
company's portfolio. They represent EW Nutrition's answer to gut and 
respiratory health issues, as well as toxin risk management. "We are pleased to 
bring our programs closer to our customers, further increasing service levels," 
says Michael Gerrits, Managing Director, EW Nutrition. "But we are even more 
pleased and honored to bring here our mission of mitigating the impact of 
antimicrobial resistance by providing comprehensive animal nutrition solutions."

The virtual opening will take place at the Melia Hotel in Shanghai, to be 
followed by a one and a half-day symposium on "Reducing Antibiotic Use and 
Mitigating the AMR Risk - 2020 Vision". Speakers include Prof. Chen Junshi, 
Prof. Jia Yanxiong, Prof. Suwit Chotinun, as well as other prestigious national 
and international guests.

About EW Nutrition

EWN Biotechnology Ltd. is the Chinese arm of EW Nutrition, an international 
animal nutrition company that offers integrators, feed producers, and 
self-mixing farmers comprehensive animal nutrition solutions for antibiotic 
reduction, young animal nutrition, toxin risk management and more.

Press contact
Caroline Gong 
Marketing Manager, China
Email: caroline.gong@ew-nutrition.com
Phone: +86-021-6029-2278

SOURCE: EW Nutrition GmbH